Neal James R

SEC CIK: 0001600865

SEC filings (opens in a new tab)

In the past year, 1 open-market purchase filing worth $2.00K and no sales.

Current role at each company

PCSA Processa Pharmaceuticals, Inc.Directoras of Jul 28, 2026
AKTX Akari Therapeutics PlcDirectoras of Mar 16, 2026
PKBO Peak Bio, Inc.Directoras of Nov 18, 2024
PALI Palisade Bio, Inc.Directoras of Feb 13, 2024
XOMA XOMA Royalty CorpCEOas of Jul 18, 2022

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought: $2.00K; 1 filing
Sold: –; 0 filings
Net: +$2.00K; Bought minus sold
Companies: 1; With open-market trades

Trades

Every Form 4 that lists Neal James R as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Transaction type

Role

Minimum value (USD)

Filed from

Filed to

Filing delay at least (days)

Filing delay at most (days)

PCSA Processa Pharmaceuticals, Inc.

Director1 trade

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Apr 2, 2026 (view filing)	Mar 31	2 days	Neal James RDirector	PPurchase	+789	$2.54	+$2.00K	+2,720.7%818 after

AKTX Akari Therapeutics Plc